Compare Sundrug Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 3.54% CAGR growth in Operating Profits over the last 5 years
2
Poor long term growth as Operating profit has grown by an annual rate 3.54% of over the last 5 years
3
The company has declared Negative results for the last 9 consecutive quarters
4
With ROE of 11.22%, it has a very attractive valuation with a 1.61 Price to Book Value
5
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-2.02%
0%
-2.02%
6 Months
-12.63%
0%
-12.63%
1 Year
-20.59%
0%
-20.59%
2 Years
-5.85%
0%
-5.85%
3 Years
-10.33%
0%
-10.33%
4 Years
19.16%
0%
19.16%
5 Years
4.18%
0%
4.18%
Sundrug Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
5.63%
EBIT Growth (5y)
3.54%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
2.64
Tax Ratio
31.46%
Dividend Payout Ratio
48.82%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
20.96%
ROE (avg)
11.53%
Valuation key factors
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.61
EV to EBIT
9.23
EV to EBITDA
6.60
EV to Capital Employed
1.66
EV to Sales
0.51
PEG Ratio
4.53
Dividend Yield
NA
ROCE (Latest)
17.93%
ROE (Latest)
11.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
206,805.00
198,217.00
4.33%
Operating Profit (PBDIT) excl Other Income
15,379.00
14,419.00
6.66%
Interest
125.00
61.00
104.92%
Exceptional Items
-117.00
-54.00
-116.67%
Consolidate Net Profit
7,161.00
6,920.00
3.48%
Operating Profit Margin (Excl OI)
49.80%
48.80%
0.10%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 4.33% vs 6.68% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 3.48% vs 9.06% in Mar 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
842,512.00
801,811.00
5.08%
Operating Profit (PBDIT) excl Other Income
65,708.00
61,894.00
6.16%
Interest
384.00
164.00
134.15%
Exceptional Items
-272.00
-292.00
6.85%
Consolidate Net Profit
31,392.00
30,750.00
2.09%
Operating Profit Margin (Excl OI)
55.60%
55.50%
0.01%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 5.08% vs 6.66% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 2.09% vs 5.58% in Mar 2025
About Sundrug Co., Ltd. 
Sundrug Co., Ltd.
Retailing
No Details Available.
Company Coordinates 
No Company Details Available






